Choksi Laboratories

quarterly
yearly
ParticularsMar '23Jun '23Sep '23Dec '23Mar '24
Revenue9.788.888.008.7911.18
Expenses8.678.667.998.659.90
EBITDA3.472.432.162.253.55
EBIT4.311.040.750.822.06
Profit Before Tax3.380.220.010.141.28
Net Profit2.990.360.010.060.68
Financial Ratios
Operating Profit Margin59.13%27.52%27.17%25.60%31.92%
Net Profit Margin10.22%4.08%0.13%0.68%6.12%
Earning Per Share (Diluted)4.290.510.010.090.98
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.1.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ